An effort by President Trump’s administration to curb advertising for pharmaceutical drugs on television is posing a ...

While it has merit as a policy measure, it's the latest in a brutal series of administration actions that have hurt ...

Regeneron Chief Executive Leonard Schleifer said he welcomed the FDA ensuring that drugmakers don’t exaggerate their products ...

Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its decision to voluntarily withdraw OCALIVA® (obeticholic acid) from the US market ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Emergent BioSolutions Inc. (NYSE: EBS) today announced that a contract modification has been executed in the amount of $56 million to supply ACAM2000 ®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) to ...